Steps to Starting a Personalized Program If you are ready to explore medical weight loss, the process should be simple and transparent
Retatrutide, an innovative agent undergoing Phase III trials for obesity, T2DM, and non-alcoholic fatty liver disease, has demonstrated encouraging outcomes
Whilst once-weekly preparations such as semaglutide and dulaglutide can be administered at any time of day, other formulations have more specific timing requirements
How Kind Patches won wellness sticker category growth in 2025 Wellness stickers had a meteoric rise in 2025, growing in online popularity by up to 2,700% year over year, with popularity spikes across six key categories
In one clinical trial of semaglutide, researchers calculated that people with type 2 diabetes can expect to lose about one-third less body weight than people without type 2 diabetes
Semaglutide, with its 7-day half-life, maintains therapeutic plasma concentrations continuously, producing consistent 24-hour receptor activation and clinically meaningful metabolic improvements
